CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Carcinoma 256, Walker D002279 22 associated lipids
Birth Weight D001724 23 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Hyperinsulinism D006946 27 associated lipids
Insulinoma D007340 28 associated lipids
Kidney Diseases D007674 29 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Uremia D014511 33 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Elbim C et al. Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst. 1998 Am. J. Pathol. pmid:9546369
Okayasu T et al. Cytochalasin delays but does not prevent cell death from anoxia. 1984 Am. J. Pathol. pmid:6541879
O'Flaherty JT et al. Neutrophil aggregation and degranulation. Effect of arachidonic acid. 1979 Am. J. Pathol. pmid:453323
O'Flaherty JT et al. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. 1981 Am. J. Pathol. pmid:7223864
O'Flaherty JT et al. Substances which aggregate neutrophils. Mechanism of action. 1978 Am. J. Pathol. pmid:356621
Ogawa H et al. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release. 1981 Am. J. Pathol. pmid:7294162
Mease AD et al. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. 1981 Am. J. Pathol. pmid:7258298
White JG and Rao GH Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. 1998 Am. J. Pathol. pmid:9466587
Webster RO et al. Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a. 1986 Am. J. Pathol. pmid:3789092
Ginsberg M et al. Mechanisms of platelet response to monosodium urate crystals. 1979 Am. J. Pathol. pmid:426039
Liu S et al. Dynamic modulation of cytoskeleton during in vitro maturation in human oocytes. 2010 Am. J. Obstet. Gynecol. pmid:20579967
Kniss DA et al. Expression of functional insulin-like growth factor-I receptors by human amnion cells. 1993 Am. J. Obstet. Gynecol. pmid:8372873
Sato N et al. Hyposmolarity stimulates myeloperoxidase exocytosis from human polymorphonuclear leukocytes. 1990 Am. J. Med. Sci. pmid:2159710
Mooradian AD and Morin AM Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. 1991 Am. J. Med. Sci. pmid:2000888
Jacobs DB Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport. 1985 Am. J. Med. pmid:3931463
Wann JG et al. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling. 2006 Am. J. Kidney Dis. pmid:16731301
Standley PR and Rose KA Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. 1994 Am. J. Hypertens. pmid:8031552
Berkow RL and Dodson RW Functional analysis of the marginating pool of human polymorphonuclear leukocytes. 1987 Am. J. Hematol. pmid:3026170
Bondareff W and Tuttle RL Cortical cytoplasm and configurational changes of RGC-6 cells exposed to cytochalasin B. 1975 Am. J. Anat. pmid:1211367
Holtzer H et al. Effects of cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4413125